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Lymphodepleting whole body irradiation (WBI) can
enhance adoptive T cell transfer-mediated tumor regres-
sion in a variety of experimental models and a subset of
patients. We investigated the potential of this approach
to impact established prostate cancer using the clinically
relevant and immunosuppressive TRAMP model of pro-
static adenocarcinoma. 18-week-old TRAMP mice bear-
ing high-grade prostatic intraepithelial neoplasia (PIN)
were treated with 475cGy WBI followed by adoptive
transfer of naïve T cell receptor transgenic CD8+ T
cells (TCR-IV) specific for the Site IV determinant in
SV40 T-antigen. TCR-IV cells proliferated in both irra-
diated and non-irradiated TRAMP mice, but accumu-
lated to significantly higher levels and persisted for
21 days in irradiated mice. Neither treatment group
developed a population of IFNg-producing TCR-IV cells
in the prostate, but a significantly larger number of
Granzyme B-producing cells infiltrated the prostates of
mice conditioned with WBI. The addition of WBI also
delayed the onset of tolerance, as the TCR-IV cells in
irradiated mice remained responsive to immunization.
WBI alone and WBI with adoptive transfer tended to
reduce the size of the urogenital tract and reduce the
incidence of adenocarcinoma at 28 weeks of age, but no
regressions were observed. However, a subset of TRAMP
mice treated with two rounds of WBI-enhanced adoptive
immunotherapy exhibited only low- or moderate-grade
PIN at 28 weeks of age, indicative of tumor regression.
The remainder of mice in this group exhibited no disease
progression beyond high-grade PIN, and all mice in the
group maintained a detectable population of TCR-IV
cells 49 days after the second adoptive transfer. In con-
trast, at least a subset of mice in remaining groups
progressed to adenocarcinoma, and all lacked detectable
TCR-IV cells. These results demonstrate that WBI condi-
tioning extends the persistence of effector phenotype
tumor-specific T cells in the highly tolerogenic microen-
vironment of the tumor-bearing TRAMP prostate, and
suggest that multiple rounds of therapy can promote
regression of established prostate lesions.
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